Quick Summary
- Arm exceeded Q4 projections with earnings per share of $0.60 versus the anticipated $0.58, and revenue reaching $1.49B compared to $1.47B consensus
- Shares surged 12-13% in extended trading before reversing course to drop 5%
- AGI CPU orders topped $2 billion, yet manufacturing capacity secured covers only half that amount
- Production limitations kept executives from increasing revenue projections
- The company is transitioning from its traditional licensing approach to producing proprietary AI processors, increasing operational expenses
Arm Holdings delivered better-than-anticipated results for its fiscal fourth quarter of 2026, yet shares couldn’t maintain their initial momentum. Following an early surge of up to 13% during after-hours trading, ARM declined more than 5% as market participants focused on manufacturing capacity challenges.
Arm Holdings plc American Depositary Shares, ARM
The semiconductor designer posted adjusted earnings of $0.60 per share against revenue of $1.49 billion. Wall Street consensus had projected $0.58 per share on $1.47 billion in sales.
Licensing revenue increased 29% from the prior year to $819 million. Royalty revenue advanced 11% year-over-year, reaching $671 million.
The initial stock surge reflected the positive numbers. The subsequent retreat reflected commentary from management.
Chief Executive Rene Haas revealed that orders for Arm’s newly launched AGI CPU — introduced in March — have already exceeded $2 billion merely six weeks post-launch, representing more than twice the initial announcement figures. This represents the encouraging aspect.
The challenge lies in manufacturing capacity. Leadership acknowledged securing sufficient wafers, memory components, and packaging materials to satisfy only the initial $1 billion of demand. The additional $1 billion remains under negotiation.
Raymond James analyst Simon Leopold highlighted that production bottlenecks caused management to refrain from increasing revenue projections.
Manufacturing Constraints Trigger Selloff
The disconnect between $2 billion in customer demand and $1 billion in verified production capability seemed to trigger the overnight stock reversal.
Arm’s Q1 2027 outlook projected adjusted EPS of $0.40, plus or minus $0.04, with revenue of $1.26 billion, plus or minus $50 million. Wall Street consensus anticipated $1.25 billion in revenue, indicating guidance aligned with expectations.
Notwithstanding the earnings beat and robust AGI CPU order figures, market participants seemed hesitant to overlook the execution uncertainty surrounding supply.
Shifting to a Capital-Heavy Strategy
Historically, Arm operated an asset-light business — licensing processor architectures to Apple, Qualcomm, Nvidia, and Samsung, then earning royalty payments on each unit shipped.
Currently, the organization is entering chip manufacturing. The AGI CPU represents Arm’s inaugural proprietary processor targeting AI infrastructure, necessitating procurement of cutting-edge 3nm wafers from TSMC and oversight of its production operations.
This represents a significantly more capital-demanding approach. Industry analysts have cautioned that elevated expenses could compress profit margins without corresponding revenue acceleration.
Arm leadership conveyed optimism in their investor communication. “The trajectory is unmistakable: clients want Arm powering AI data centers,” Haas and CFO Jason Child stated.
They additionally indicated the data center division is progressing toward a $15 billion revenue objective and anticipate it becoming Arm’s primary business segment.
ARM shares have climbed over 115% during 2026, establishing elevated expectations heading into the quarterly report. Analyst consensus currently reflects a Strong Buy rating, comprising 18 Buy recommendations, 3 Hold ratings, and 1 Sell rating across the previous three months.
The consensus analyst price target stands at $188.52 per share.
